Rituximab Treatment for Relapsing Minimal Change Disease and Focal Segmental Glomerulosclerosis: A Systematic Review
Author:
Publisher
S. Karger AG
Subject
Nephrology
Reference54 articles.
1. Adult Minimal-Change Disease: Clinical Characteristics, Treatment, and Outcomes
2. Focal Segmental Glomerulosclerosis in Nephrotic Adults: Presentation, Prognosis, and Response to Therapy of the Histologic Variants
3. Focal and Segmental Glomerulosclerosis: Definition and Relevance of a Partial Remission
4. Prevention and treatment of systemic glucocorticoid side effects
5. Clinical trial of focal segmental glomerulosclerosis in children and young adults
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nephrotic syndrome due to focal segmental glomerulosclerosis complicating scleroderma: a case report;Journal of Medical Case Reports;2024-01-15
2. Efficacy of Rituximab for Minimal Change Disease and Focal Segmental Glomerulosclerosis with Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome in Adults: A Chinese Multicenter Retrospective Study;American Journal of Nephrology;2023-11-14
3. Case report: Early onset de novo FSGS in a child after kidney transplantation—a successful treatment;Frontiers in Pediatrics;2023-09-26
4. A Systematic Review and Meta-analysis of Rituximab-Associated Infections Among Children and Adolescents With Glomerular Disease: Focus on the Risk of Infections;The Journal of Pediatric Pharmacology and Therapeutics;2023-08-01
5. Primary Nephrotic Syndrome;Nephrology Self-Assessment Program;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3